HUMAN LYMPHOCYTE ANTIGENS IN GRAVES-DISEASE - CORRELATION WITH PERSISTENT COURSE OF DISEASE

被引:12
作者
BALDINI, M
PAPPALETTERA, M
LECCHI, L
ORSATTI, A
MERONI, L
TOZZI, R
SCALAMOGNA, M
CANTALAMESSA, L
机构
[1] OSPED MAGGIORE POLICLIN, CATTEDRA MED INTERNA PAD GRANELLI, CTR TRASFUS & IMMUNOL TRAPIANTI, I-20121 MILAN, ITALY
[2] UNIV MILAN, IST MED INTERNA MALATTIE INFETT & IMMUNOPATHOL, MILAN, ITALY
关键词
GRAVES DISEASE; GRAVES OUTCOME; HLA ANTIGENS;
D O I
10.1097/00000441-199501000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graves' disease is a thyroid autoimmune disorder associated with specific human lymphocyte antigen (HLA) alleles, characterized by an unpredictable long-term course. To investigate possible relations between HLA phenotype and outcome of the disease, the authors typed for HLA antigens in 105 patients with Graves' disease with different course of disease. Al]. patients were treated with antithyroid drugs for at least 12 months; 29 patients had stable remission 24 or more months after withdrawal of treatment; 76 patients had persistent disease-66 unremitting/relapsing hyperthyroidism, 10 stable hypothyroidism-36 or more months after onset of disease. The following findings emerged from this study: 1) HLA B8 and DR3 were increased significantly in Graves' patients versus 6,682 control subjects from the same geographic area (23.80% vs 12.01%, odds ratio [OR] 1.98, and 31.43% vs 18.00%, OR 1.75, respectively); the antigen combinations B8-DR3, B8-Cw7-DR3, and A1-B8-Cw7-DR3 were significantly more frequent in Graves' patients vs control subjects; in addition, these combinations were present exclusively in patients with persistent disease (B8-DR3 28.95%, OR 7.14, B8-Cw7-DR3 27.63%, OR 11.24, and A1-B8-Cw7-DR3 18.42%, OR 11.29). These data provide evidence that not only susceptibility to Graves' disease, but also persistent activity of the autoimmune process, producing either hyperthyroidism or stable hypothyroidism, is associated with specific HLA antigen phenotypes.
引用
收藏
页码:43 / 48
页数:6
相关论文
共 31 条
[1]   SERUM THYROGLOBULIN CONCENTRATION AS AN INDICATOR FOR ASSESSING THYROID-STIMULATION IN PATIENTS WITH GRAVES-DISEASE DURING ANTITHYROID DRUG-THERAPY [J].
AIZAWA, T ;
ISHIHARA, M ;
KOIZUMI, Y ;
HASHIZUME, K ;
TAKASU, N ;
YAMADA, T ;
KOBAYASHI, I ;
WATANABE, T ;
SHIMIZU, Z .
AMERICAN JOURNAL OF MEDICINE, 1990, 89 (02) :175-180
[2]   HLA AND GRAVES-DISEASE - AN ASSOCIATION WITH HLA-DRW3 [J].
ALLANNIC, H ;
FAUCHET, R ;
LORCY, Y ;
HEIM, J ;
GUEGUEN, M ;
LEGUERRIER, AM ;
GENETET, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (04) :863-867
[3]   A PROSPECTIVE-STUDY OF THE RELATIONSHIP BETWEEN RELAPSE OF HYPERTHYROID GRAVES-DISEASE AFTER ANTI-THYROID DRUGS AND HLA HAPLOTYPE [J].
ALLANNIC, H ;
FAUCHET, R ;
LORCY, Y ;
GUEGUEN, M ;
LEGUERRIER, AM ;
GENETET, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 57 (04) :719-722
[4]  
BOEHM BO, 1992, CLIN INVESTIGATOR, V70, P956
[5]  
CROSBY I, 1989, UKTS B MAY
[6]   THYROTROPIN-RELEASING-HORMONE TESTING DURING ANTITHYROID DRUG-TREATMENT OF GRAVES-DISEASE AS AN INDICATOR OF REMISSION [J].
DAHLBERG, PA ;
KARLSSON, FA ;
JANSSON, R ;
WIDE, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1985, 61 (06) :1100-1104
[7]   HLA-A, HLA-B, HLA-C AND HLA-DR ANTIGENS IN PATIENTS WITH GRAVES-DISEASE AND THEIR CORRELATION WITH SIGNS AND CLINICAL COURSE [J].
DAHLBERG, PA ;
HOLMLUND, G ;
KARLSSON, FA ;
SAFWENBERG, J .
ACTA ENDOCRINOLOGICA, 1981, 97 (01) :42-47
[8]   GRAVES-DISEASE - IMMUNOLOGICAL AND IMMUNOGENETIC INDICATORS OF RELAPSE [J].
DEBRUIN, TWA ;
BOLK, JH ;
BUSSEMAKER, JK ;
STIJNEN, T ;
SCHREUDER, GMT ;
DEVRIES, RRP ;
VANDERHEIDE, D .
BRITISH MEDICAL JOURNAL, 1988, 296 (6632) :1292-1295
[9]  
GARDNER MJ, 1989, STATISTICS CONFIDENC
[10]   RETROSPECTIVE REVALUATION OF THE SIGNIFICANCE OF THYROID MICROSOMAL ANTIBODY IN THE TREATMENT OF GRAVES-DISEASE [J].
HAMADA, N ;
ITO, K ;
MIMURA, T ;
ISHIKAWA, N ;
MOMOTANI, N ;
NOH, J ;
HOSODA, Y ;
MORII, H .
ACTA ENDOCRINOLOGICA, 1987, 114 (03) :328-335